Welcome to Johns Hopkins Health Alerts!

"Johns Hopkins Health Alerts is an excellent site and I have recommended it to several of my friends. Thanks again, and keep up the good work!"
  • - D. Ambrosio

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging.

Get the latest news sent straight to your inbox for FREE. Check all the boxes below for the topics that interest you.
We value your privacy and will never rent your email address

Johns Hopkins Health Alert

How Long Can You Safely Take Bisphosphonate Medication for Osteoporosis?

Comments (0)

Bisphosphonates are the drugs most often prescribed to treat and prevent osteoporosis. Bisphosphonates help to preserve bone mass by slowing down bone resorption. Clinical studies of these drugs have focused on their effect on bone mineral density (BMD) and fracture risk. Members of this drug class include Fosamax, ibandronate (Boniva), Actonel and Reclast.  

A reader asks:  I took one bisphosphonate for four years and another for one year; however, the changes to my BMD have been minimal. Now my doctor suggests continuing the medication I'm on for another year, but I've heard you shouldn't take a bisphosphonate for more than five years. What is my next step? 

Here’s our advice:  Guidelines for long-term use of bisphosphonates from groups like the National Osteoporosis Foundation have recently been updated to reflect new findings on the benefits and risks of that class of drugs. That said, however, there is no one-size-fits-all approach to taking bisphosphonates for osteoporosis.

Instead, there are several factors, including age, BMD, fracture history, family history, exposure to drugs like corticosteroids, smoking history, alcohol use and activity level, that help doctors determine a person's risk of bone fracture from osteoporosis.

People who are at low risk for fractures may be able to stop using bisphosphonates within five years. People who are at higher risk, however, might be advised to continue using bisphosphonates for up to 10 years. Ask your doctor what risk category you are in and discuss the benefits and risks of long-term bisphosphonate use. Also discuss what other treatment options might be appropriate for you. 

Posted in Osteoporosis on April 22, 2011

Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer

Notify Me

Would you like us to inform you when we post new Osteoporosis Health Alerts?

Post a Comment


Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.

Post a Comment

Already a subscriber?


Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

Customer Service

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Johns Hopkins’ Back Pain and Osteoporosis Bestsellers

Johns Hopkins White Papers

  • 2014 Back Pain and Osteoporosis White Paper
    A lifetime of walking, standing, lifting, and twisting causes significant low back pain in 80% of all adults. And as our population continues to age, osteoporosis becomes an increasingly widespread problem. In the Back Pain and Osteoporosis White Paper, Johns Hopkins experts discuss sprains, strains, spasms, disk herniation, degenerative changes in the disks and spine, spinal stenosis, and osteoporosis, a common cause of hip and spine fractures. You will explore causes of back pain, learn about preventive steps and pain relief, and examine treatments that include the latest drug and surgical options.
    Click here to read more or order now

Related Titles:

  • Making the Right Decisions About Knee Replacement Surgery If you're facing knee replacement surgery and wonder what to expect, our authoritative 50–page guide can help. The report presents the latest thinking on knee replacement surgery from specialists who perform the surgery regularly. It includes answers to dozens of real questions from patients like you, plus in–depth discussions on the physiology of the knee . . . knee replacement surgical techniques . . . arthritis management, medication advice and other important information to guide you through the steps and decisions you face as you weight your options.
    Read more or order Making the Right Decisions About Knee Replacement Surgery
  • 2014 Arthritis White Paper
    Arthritis now affects over 70 million Americans. The Johns Hopkins 2014 Arthritis White Paper provides in-depth knowledge on the most recent breakthroughs concerning the most common forms of arthritis-osteoarthritis and rheumatoid arthritis. In addition, it includes two other rheumatic diseases: fibromyalgia syndrome and bursitis, and also ankylosing spondylitis, gout, and lyme disease.
    Click here to read more or order
  • The Johns Hopkins Medical Letter: Health After 50
    Since 1988, Hopkins experts have been reporting the latest cutting-edge information on treating the major medical conditions affecting those over 50. Women's health, men's medical concerns, nutrition, weight control, breakthroughs on back pain and osteoporosis, and more, direct to you from our specialists. Read more, or order now...

Health Topic Pages

  • Health Alert
  • Special Report

What is this?